focus -WSS

focus

author：leisure time 2025-09-27 10:03:18 - browse：999

Erik Tokat -- biotech JPM coverage from STAT — Eric Tokat is co-president of investment banking at Centerview Partners. Courtesy Centerview Partners

SAN FRANCISCO — Eric Tokat, biotech’s most prolific dealmaker, believes 2024 will be another strong year for acquisitions, driven by Big Pharma’s need to restock pipelines with medicines that can generate sales in the coming years.

That’s not idle speculation. It’s perhaps as close to a guarantee one can get in biotech. Last year, Tokat’s advisory firm, Centerview Partners, was involved in 19 of the 23 biotech transactions valued at $1 billion or more. Two more acquisitions of Centerview clients — Harpoon Therapeutics and Ambrx Biopharma — were announced Monday morning.

“I’m not sure if we’re going to have 23 deals or 25 deals, but I think it’s going to be a good year,” said Tokat, speaking to STAT over coffee on the sidelines of the J.P. Morgan Healthcare Conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Lilly's Alzheimer's drug donanemab backed by FDA advisers

leisure time

WSS

After a decade, new Gardasil ad campaign gets it (mostly) right

5 takeaways from STAT's examination of Zynex Medical

Are infertility treatments 'essential' during the Covid

Dementia risk linked to living in disadvantaged areas: Study

FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

hotspot

focus

hotspot

Cancer drug shortages should be causing more outrage

NIH tests clinical research in primary care with $30 million program

Hepatitis C has a cure — but many Americans still lack access to it

Mystery swirls around US soldier who entered North Korea days ago, officials say

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Thousands of UK hospital doctors walk out in the latest pay dispute, crippling health services

Medicare proposal to cover medical devices draws a mixed reaction

Moderna says combo Covid

How one medical school became remarkably diverse

Judge denies Trump's request for new trial in E. Jean Carroll case

knowledge

Report captures long Covid’s disabling effects and policy challenges

After a decade, new Gardasil ad campaign gets it (mostly) right

Pharma companies must ensure equitable access to obesity drugs

ALS patient reclaims some autonomy thanks to wearable 'robot'

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

STAT Virtual Event: ASCO Recap, Live!

hotspot

Wikipedia

leisure time

focus